Biohaven Pharma to continue late-stage study of Alzheimer's treatment
December 06, 2019 at 07:51 AM EST
Biohaven Pharmaceutical said on Friday it would continue with a late-stage study of its experimental Alzheimer's treatment on the recommendation of an independent data-monitoring committee based on an interim analysis of results.